secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001193125-26-027462
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica discontinues Phase 2 KOURAGE trial, extends cash runway to Q4 2026
------------------------------------------------------------------------------

- Phase 2 KOURAGE trial discontinued following IDMC recommendation.
- Cash runway guidance updated: existing cash, equivalents, and short-term investments expected to fund operations into Q4 2026.
- Previously disclosed guidance expected funding into second half of 2026.
- No specific financial amounts or trial data disclosed in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312526027462/0001193125-26-027462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312526027462/d40225d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-027462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer